Delivery Order SPE2DB20D3101-SPE2DB25FRSZ4
- Not listed
- This is a $1,330.65 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 2.5 mg/ml clobazam suspension in a 120 ml bottle. The delivery order has an ultimate completion date of July 7, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10 mg tablets in a quantity of 100 units, with a ceiling value of $7,124.30. This firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award was made on a competitive, non-set-aside basis, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,622.52 on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 15, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $5,030.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10mg tablets in a quantity of 100 units, with a contract ceiling value of $3,111.86. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $1,567.49, is for the provision of clobazam 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a delivery order valued at $1,626.48 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSZ4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Clobazam 2.5 mg/ml suspension in a 120ml unit at a firm fixed price of $1,909.32. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 20, 2025. This pharmaceutical supply falls under AmerisourceBergen's broader engagement with the federal government as a critical vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive vehicle enables AmerisourceBergen to supply pharmaceutical products and medical commodities globally to support military healthcare programs, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's performance of this delivery order demonstrates its continued role as a primary pharmaceutical distributor within the DLA's medical supply chain, particularly for neurological and specialty medications supporting defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 8/19/25 |